Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
株式のランク #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
株価
$0.0202
最終同期: 2024-11-19
時価総額
$44.67K
変化(1日)
-0.49%
変化(1年)
0.00%
IL
取引 Notable Labs, Ltd. (NTBL)

カテゴリー

Notable Labs, Ltd.(NTBL)のEPS
June 2024 時点のEPS TTM: $-0.97
Notable Labs, Ltd.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-0.97です。2022年末には、EPSは$-6.50で、2021年のEPS$-0.22と増加でした。
Notable Labs, Ltd.のEPS履歴(2015から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-0.97 -80.72%
2023 $-5.03 -22.62%
2022 $-6.50 2,854.55%
2021 $-0.22 -54.17%
2020 $-0.48 26.32%
2019 $-0.38 -38.71%
2018 $-0.62 67.57%
2017 $-0.37 -42.19%
2016 $-0.64 -12.33%
2015 $-0.73 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -1,885.57%
US
$27.74 -2,959.79%
NL
- -
CH
- -
KR
$13.70 -1,512.38%
BE